NCT06828354 2025-03-24A Study of SHR-A1811 in Subjects With Ovarian CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Recruiting300 enrolled
NCT03180307 2022-02-04OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerOn Target Laboratories, LLCPhase 3 Completed140 enrolled 11 charts 2 FDA
NCT00057720 2011-07-25TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian CancerTelikPhase 3 Completed440 enrolled